[ Price : $8.95]
A Newsweek report details four major issues it says have plagued FDA in its first year under commissioner Marty Makary.[ Price : $8.95]
FDA releases the Form 483 behind a 3/5 Warning Letter to Novo Nordisk that cited serious violations of postmarketing adverse drug ...[ Price : $8.95]
FDA warns Indias Tentamus India Private Limited contract laboratory about significant violations of CGMP regulations.[ Price : $8.95]
FDA warns Exactech, doing business as Advita Ortho, about Quality System violations in its production of accessories for the Equin...[ Price : $8.95]
FDA posts a 3/5 complete response letter to Rosemont Pharmaceuticals, rejecting the companys NDA for valacyclovir.[ Price : $8.95]
FDA warns Westphalia, Germany-based Simtra BioPharma Solutions about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA warns Novo Nordisk in Plainsboro, NJ, about its failure to meet postmarketing adverse drug experience reporting requirements.[ Price : $8.95]
FDA warns Frances Fareva about CGMP violations in the production of finished drugs at its Morton Grove, IL, manufacturing facility...